Remote Treatment of Alcohol Withdrawal

Status Completed

Clinical Trial Summary

This study will evaluate the feasibility of delivering symptom-triggered alcohol withdrawal management by telemedicine and determine whether this intervention is satisfactory to patients.

Clinical Trial Description

This single-arm pilot feasibility study will recruit actively drinking participants with a history of alcohol withdrawal in order to provide remotely monitored symptom-triggered alcohol withdrawal treatment using telemedicine. Participants will initially complete a screening and eligibility visit. If eligible, participants will then be scheduled for 3-day remote withdrawal management (which can be extended by 1-2 days if medically indicated). During remote withdrawal management, participants will receive symptom-triggered diazepam treatment using a modified version of the Clinical Institute Withdrawal Assessment for Alcohol Scale, revised (CIWA-Ar). Within one week following termination of withdrawal treatment, participants will be scheduled for a remote follow up visit in which they will complete patient satisfaction questionnaires and will be offered weekly counselling sessions and anticraving medication to prevent relapse to alcohol use. Approximately 30 days following treatment initiation, relapse to alcohol use will be assessed. ;

Study Design

Related Conditions & MeSH terms

Alcohol Withdrawal

Clinical Trial Details

NCT number	NCT04858490
Study type	Interventional
Source	Centre for Addiction and Mental Health
Contact
Status	Completed
Phase	N/A
Start date	September 24, 2021
Completion date	November 21, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03916939` - Osteopathic Treatment to Alcohol Withdrawal Syndrome	N/A
Not yet recruiting	`NCT04997330` - Evaluation of Bilateral HF-rTMS on Abstinence in Alcohol Use Disorder Patients With Executive Dysfunction	N/A
Recruiting	`NCT04876443` - Impact of COVID-19 Outbreak on the Alcohol Consumption in Patients With Alcohol-related Liver Disease (ICoLD)
Completed	`NCT05131334` - Auricular Vagal Stimulation in Alcohol Craving	N/A
Completed	`NCT02349477` - Gabapentin for Alcohol Relapse Prevention	Phase 2
Terminated	`NCT01937364` - Preventing Alcohol Withdrawal With Oral Baclofen	Phase 2
Completed	`NCT05393544` - Digitally Assisted Recovery Coach	N/A
Completed	`NCT00523185` - A Comparison of Lorazepam and Diazepam in the Treatment of Alcohol Withdrawal	N/A
Completed	`NCT01573052` - Gabapentin vs Chlordiazepoxide for Ambulatory Alcohol Withdrawal	Phase 4
Enrolling by invitation	`NCT06173973` - Effects of Ketone Supplementation on Acute Alcohol Withdrawal	Phase 2/Phase 3
Active, not recruiting	`NCT03737864` - NCARE, Transition to Recovery	N/A
Recruiting	`NCT03878225` - Does a Ketogenic Dietary Supplement Reduce Alcohol Withdrawal Symptoms in Humans?	N/A
Terminated	`NCT03586089` - Phenobarbital for Severe Acute Alcohol Withdrawal Syndrome	N/A
Recruiting	`NCT04156464` - Phenobarbital vs Ativan for Alcohol Withdrawal in the Intensive Care Unit	Phase 4
Completed	`NCT02251912` - Oxytocin Treatment of Alcohol Dependence	Phase 2
Completed	`NCT02202148` - Liver Stiffness Measurement in Alcohol-dependent Subjects in Relation to Abstinence After Withdrawal	N/A
Completed	`NCT01212185` - Oxytocin Treatment of Alcohol Withdrawal	Phase 1
Recruiting	`NCT04793685` - Prazosin for Alcohol Use Disorder With Withdrawal Symptoms	Phase 1/Phase 2
Withdrawn	`NCT04159909` - Using Transcutaneous Auricular Vagus Nerve Stimulation to Treat Acute Alcohol Withdrawal	N/A
Completed	`NCT05563350` - Metabolism of Chlordiazepoxide in the Treatment of Alcohol Withdrawal Symptoms